title: [Tumors in rheumatic diseases].
abstract: Patients with systemic inflammatory rheumatic diseases (such as rheumatoid arthritis, lupus erythematosus, systemic sclerosis, idiopathic inflammatory myopathies, or Sjögren's syndrome) are at increased risk of cancer, including hematological malignancies (leukemias and lymphomas), as well as non-hematological cancers (e.g. lung, esophageal, prostate or ovarian cancer). This increased risk for cancer development in patients with rheumatic diseases is attributed to the immune (autoimmune) processes and the medical treatment. Due to the often similar symptoms and the occurrence of systemic paraneoplastic syndromes it is very important to evaluate the association between rheumatic diseases and cancer. This paper presents issues concerning the development of cancer in patients with rheumatic diseases and the risk of cancer associated with drugs used for the treatment of rheumatic diseases.
authors.affiliation: Klinika Reumatologii i Chorób Wewnętrznych, Uniwersytet Medyczny we Wrocławiu.
authors.forename: Jerzy
authors.initials: J
authors.lastname: Świerkot
authors.affiliation: III Katedra Pediatrii, Klinika Immunologii i Reumatologii Wieku Rozwojowego, Uniwersytet Medyczny we Wrocławiu; Oddział Immunologii Klinicznej i Pediatrii, WSS. im. J.Gromkowskiego we Wrocławiu.
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Lewandowicz-Uszyńska
authors.affiliation: Laboratorium Immunogenetyki Klinicznej i Farmakogenetyki, Instytut Immunologii i Terapii Doświadczalnej PAN im. L. Hirszfelda we Wrocławiu.
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Bogunia-Kubik
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000453:epidemiology; D001327:Autoimmune Diseases / Q000453:epidemiology*; D015897:Comorbidity; D003937:Diagnosis, Differential; D006801:Humans; D007938:Leukemia / Q000453:epidemiology*; D008180:Lupus Erythematosus, Systemic / Q000453:epidemiology; D008223:Lymphoma / Q000453:epidemiology*; D009369:Neoplasms / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology*; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000453:epidemiology*; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000453:epidemiology*; D012307:Risk Factors